Document is current
Any future updates will be listed below
-
Authors
Weichsel, Loris
André, Florian
Renker, Matthias
Breitbart, Philipp
Overhoff, Daniel
Beer, Meinrad
Giesen, Alexander
Vattay, Borbála
Buss, Sebastian
Marwan, Mohamed
Schlett, Christopher L.
Giannopoulos, Andreas A.
Kelle, Sebastian
Frey, Norbert
Korosoglou, Grigorios https://orcid.org/0000-0002-6038-2253
,
Giusca, Sorin
Schütz, Moritz
Weberling, Lukas D.
Schmitt, Ramona
Schoenberg, Stefan O.
Kuru, Mustafa
Klömpken, Steffen
Balint, Szilveszter
Maurovitch-Horvat, Pal
Görich, Johannes
Emami, Mustafa
Kaufmann, Philipp A.
Doeblin, Patrick
Solowjowa, Natalia
Weiss, Karl Jakob
Baumann, Stefan
Stach, Ksenia
-
Clinical Trials BETA
Clinical trials referenced in this document:
drks00031954 at German Clinical Trials RegisterDocuments that mention this clinical trial
Effects of high- versus low-intensity lipid-lowering treatment in patients undergoing serial coronary computed tomography angiography: results of the multi-center LOCATE study
https://doi.org/10.1007/s00392-024-02502-6
-
Funding
Funding for this research was provided by:
Siemens Healthineers
- License Information
-
More Information
Article History
Received: 6 June 2024
Accepted: 18 July 2024
First Online: 30 July 2024
Declarations
:
: GK: received modest honoraria from Philips Healthcare, Siemens Healthineers, Cordis, Boston scientific and BARD Peripheral Vascular Inc., and institutional grants from Philips Healthcare and Bard Peripheral Vascular Inc. NF: received speaker fees from Daiichi Sankyo, Novartis, and Pfizer. SK: received an unrestricted grant from Philips Healthcare, Siemens as well as GE and was supported by the German Federal Ministry of Education and Research and the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-CRC-1470-B06. MR: received proctor fees from Boston Scientific. DO: received speaker fees from Canon medical. P.B: receives speaker honoraria and consultancy fees from AstraZeneca, Daiichi Sankyo, Novo Nordisk, and Sanofi Aventis. M.W: received speaker honoraria Edwards lifescience and Siemens healthineers and a research Grant from the 'Deutsche Herzstiftung'.
